All Outputs (1510)

FRI0511 THE DESCRIPTIVE EPIDEMIOLOGY AND SECULAR TRENDS OF LOWER BACK PAIN PROCEDURES IN ROUTINE UK NHS CARE FROM 2000 TO 2016 (2025)
Presentation / Conference Contribution
Robinson, D., Lane, J., Craig, R., Judge, A., Bailey, J., Yu, D., Jordan, K., Peat, G., Wilkie, R., Silman, A., Strauss, V., & Prieto-Alhambra, D. FRI0511 THE DESCRIPTIVE EPIDEMIOLOGY AND SECULAR TRENDS OF LOWER BACK PAIN PROCEDURES IN ROUTINE UK NHS CARE FROM 2000 TO 2016

Background:
The lifetime prevalence of lower back pain is between 60% and 70%, with surgical treatments spared for those not responding to other options.

Objectives:... Read More about FRI0511 THE DESCRIPTIVE EPIDEMIOLOGY AND SECULAR TRENDS OF LOWER BACK PAIN PROCEDURES IN ROUTINE UK NHS CARE FROM 2000 TO 2016.

SAT0445 TRABECULAR BONE SCORE IMPROVES FRACTURE RISK STRATIFICATION IN PATIENTS WITH REDUCED BONE MINERAL DENSITY (2025)
Presentation / Conference Contribution
Rakieh, C., Ho, S., & Butler, R. SAT0445 TRABECULAR BONE SCORE IMPROVES FRACTURE RISK STRATIFICATION IN PATIENTS WITH REDUCED BONE MINERAL DENSITY. Presented at EULAR 2020, online

Background:
Trabecular bone score (TBS) is a textural index of bone microarchitecture and has been found to be related to 3D bone structure. A number of cohort studies have demonstrated the value of TBS as an inde... Read More about SAT0445 TRABECULAR BONE SCORE IMPROVES FRACTURE RISK STRATIFICATION IN PATIENTS WITH REDUCED BONE MINERAL DENSITY.

PARE0030 PEER SUPPORT OF PATIENT AND PUBLIC INVOLVEMENT AND ENGAGEMENT IN RESEARCH: THE ‘RUG-BUDDY‘ (2025)
Presentation / Conference Contribution
Higginbottom, A., Rhodes, C., Campbell, L., & Blackburn, S. PARE0030 PEER SUPPORT OF PATIENT AND PUBLIC INVOLVEMENT AND ENGAGEMENT IN RESEARCH: THE ‘RUG-BUDDY‘. Presented at EULAR 2020, online

Background:
Since 2006, The School of Primary, Community and Social Care, Keele University has a long standing commitment to Patient and Public Involvement and Engagement (PPIE) in research. The School's Research... Read More about PARE0030 PEER SUPPORT OF PATIENT AND PUBLIC INVOLVEMENT AND ENGAGEMENT IN RESEARCH: THE ‘RUG-BUDDY‘.

POS1483-HPR A QUANTITATIVE ASSESSMENT OF THE LIKELIHOOD THAT PATIENTS WITH RHEUMATOID ARTHRITIS WILL COMMUNICATE INFORMATION ABOUT RHEUMATOID ARTHRITIS RISK TO RELATIVES (2025)
Presentation / Conference Contribution
Wells, I., Nightingale, P., Simons, G., Mallen, C., Raza, K., & Falahee, M. POS1483-HPR A QUANTITATIVE ASSESSMENT OF THE LIKELIHOOD THAT PATIENTS WITH RHEUMATOID ARTHRITIS WILL COMMUNICATE INFORMATION ABOUT RHEUMATOID ARTHRITIS RISK TO RELATIVES. Presented at EULAR 2021, online

Background:
First-degree relatives (FDRs) of patients with rheumatoid arthritis (RA) are at increased risk of RA and are being recruited to studies of predictive and preventive approaches. Access to FDRs is usuall... Read More about POS1483-HPR A QUANTITATIVE ASSESSMENT OF THE LIKELIHOOD THAT PATIENTS WITH RHEUMATOID ARTHRITIS WILL COMMUNICATE INFORMATION ABOUT RHEUMATOID ARTHRITIS RISK TO RELATIVES.

POS0992 PARIS STUDY: POTENTIAL BIOMARKERS PREDICTING RESPONSE TO TNFI IN PSORIATIC ARTHRITIS (2025)
Presentation / Conference Contribution
Makos, A., Grime, H., Amarasena, R., Kuiper, J., & Kehoe, O. POS0992 PARIS STUDY: POTENTIAL BIOMARKERS PREDICTING RESPONSE TO TNFI IN PSORIATIC ARTHRITIS. Presented at EULAR 2024, Vienna, Austria

Background:
Psoriatic Arthritis (PsA) is a complex immune-mediated disease. TNF inhibitors (TNFi) are the first-line biologic drugs to treat PsA, targeting soluble TNF-α (sTNF) and membrane-bound TNF-α (mTNF). TNF... Read More about POS0992 PARIS STUDY: POTENTIAL BIOMARKERS PREDICTING RESPONSE TO TNFI IN PSORIATIC ARTHRITIS.

AB0419 OUTCOMES OF THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS RECEIVING GP2015 (ETANERCEPT BIOSIMILAR) IN A REAL-WORLD STUDY: FINAL RESULTS FROM COMPACT STUDY (2025)
Presentation / Conference Contribution
Schmalzing, M., Askari, A., Sheeran, T., Jathanakodi, S., Both, C., & Kellner, H. AB0419 OUTCOMES OF THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS RECEIVING GP2015 (ETANERCEPT BIOSIMILAR) IN A REAL-WORLD STUDY: FINAL RESULTS FROM COMPACT STUDY. Presented at EULAR 2023, Milan, Italy

Background
COMPACT is an international, non-interventional cohort study evaluating the effectiveness, safety and quality of life in patients (pts) with rheumatoid arthritis (RA), axial-spondyloarthritis (axSpA) or... Read More about AB0419 OUTCOMES OF THE SELF-INJECTION ASSESSMENT QUESTIONNAIRE IN RHEUMATOID ARTHRITIS, AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS PATIENTS RECEIVING GP2015 (ETANERCEPT BIOSIMILAR) IN A REAL-WORLD STUDY: FINAL RESULTS FROM COMPACT STUDY.

POS0902 WHAT IS THE IMPACT OF CONFLICTING INFORMATION ON THE USE OF ANTI-RHEUMATIC DRUGS IN PREGNANCY AND BREASTFEEDING? LIKELIHOOD FOR APPREHENSION AND MEDICATION CESSATION REPORTED BY HEALTH CARE PROVIDERS IN THE GLOBAL PRAISE SURVEY (2025)
Presentation / Conference Contribution
Schreiber, K., Graversgaard, C., Agmon-Levin, N., Aguilera, S., Antovic, A., Bertsias, G., Bini, I., Bobirca, A., Capela, S., Cervera, R., Costedoat-Chalumeau, N., Etomi, O., Flint, J., Fonseca, J., Fritsch-Stork, R., Förger, F., Giles, I., Goulden, B., Götestam Skorpen, C., Gunnarsson, I., …Andreoli, L. POS0902 WHAT IS THE IMPACT OF CONFLICTING INFORMATION ON THE USE OF ANTI-RHEUMATIC DRUGS IN PREGNANCY AND BREASTFEEDING? LIKELIHOOD FOR APPREHENSION AND MEDICATION CESSATION REPORTED BY HEALTH CARE PROVIDERS IN THE GLOBAL PRAISE SURVEY. Presented at EULAR 2024, Vienna, Austria

Background:
Rheumatic and musculoskeletal diseases (RMDs) frequently affect individuals of childbearing age. During pregnancy, disease control is vital, as disease activity leads to adverse outcomes for both the m... Read More about POS0902 WHAT IS THE IMPACT OF CONFLICTING INFORMATION ON THE USE OF ANTI-RHEUMATIC DRUGS IN PREGNANCY AND BREASTFEEDING? LIKELIHOOD FOR APPREHENSION AND MEDICATION CESSATION REPORTED BY HEALTH CARE PROVIDERS IN THE GLOBAL PRAISE SURVEY.

AB0442 SEQUENCE: EFFECTIVENESS OF SEQUENTIAL BIOLOGIC AND TARGETED SMALL MOLECULE DMARDs IN PSORIATIC ARTHRITIS IN THE UNITED KINGDOM (2025)
Presentation / Conference Contribution
Gollins, C., Smith, T., Vivekanantham, A., Brooke, M., Coates, L., Gullick, N., Mchugh, N., Fahy, C., Chan, A., Chauhan, C., Das, D., Sin, J., Gudu, T., Johnsson, H., Mirjafari-Temple, H., Mittal, G., Packham, J., Pande, I., Rose-Parfitt, E., Williams, E., …Tillett, W. AB0442 SEQUENCE: EFFECTIVENESS OF SEQUENTIAL BIOLOGIC AND TARGETED SMALL MOLECULE DMARDs IN PSORIATIC ARTHRITIS IN THE UNITED KINGDOM. Presented at EULAR 2024, Vienna, Austria

Background:
Biologic and targeted small molecule DMARDs (b/tsDMARDs) have significantly improved outcomes for people with psoriatic arthritis (PsA). There remains a proportion of people with PsA who require multip... Read More about AB0442 SEQUENCE: EFFECTIVENESS OF SEQUENTIAL BIOLOGIC AND TARGETED SMALL MOLECULE DMARDs IN PSORIATIC ARTHRITIS IN THE UNITED KINGDOM.

POS1080 IMPLEMENTING OA TREATMENT RECOMMENDATIONS IN PRIMARY CARE POSTPONED JOINT REPLACEMENT IN HIP AND KNEE JOINTS - 8 YEAR FOLLOW-UP OF A CLUSTER RANDOMIZED CONTROLLED TRIAL (2025)
Presentation / Conference Contribution
Osteras, N., Moseng, T., Van Bodegom-Vos, L., Dziedzic, K., Natvig, B., Røtterud, J., Vliet Vlieland, T., Fenstad, A., Furnes, O., & Hagen, K. POS1080 IMPLEMENTING OA TREATMENT RECOMMENDATIONS IN PRIMARY CARE POSTPONED JOINT REPLACEMENT IN HIP AND KNEE JOINTS - 8 YEAR FOLLOW-UP OF A CLUSTER RANDOMIZED CONTROLLED TRIAL. Presented at EULAR 2024, Vienna, Austria

Background:
To improve quality of hip and knee osteoarthritis (OA) management a structured model of care was developed based on international treatment recommendations. The model was implemented among general prac... Read More about POS1080 IMPLEMENTING OA TREATMENT RECOMMENDATIONS IN PRIMARY CARE POSTPONED JOINT REPLACEMENT IN HIP AND KNEE JOINTS - 8 YEAR FOLLOW-UP OF A CLUSTER RANDOMIZED CONTROLLED TRIAL.

AB1607-HPR DEVELOPMENT OF PATIENT-REPORTED QUALITY INDICATORS FOR HAND OSTEOARTHRITIS CARE USING THE RAND/UCLA METHOD – A EUROPEAN CONSENSUS STUDY (2025)
Presentation / Conference Contribution
Bordvik, D., Prior, Y., Tveter, A., Haugen, I., Christensen, B., Berenbaum, F., Laheij, H., Edwards, J., Dziedzic, K., Ritt, M., Kloppenburg, M., Bjork, M., Osteras, N., Bamford, R., Stamm, T., Blanck, T., Borgen, T., Graham, C., Gilanliogullari, N., & Kjeken, I. AB1607-HPR DEVELOPMENT OF PATIENT-REPORTED QUALITY INDICATORS FOR HAND OSTEOARTHRITIS CARE USING THE RAND/UCLA METHOD – A EUROPEAN CONSENSUS STUDY. Presented at EULAR 2024, Vienna, Austria

Background:
Hand osteoarthritis (OA) is a prevalent rheumatic disease, yet access to recommended treatments is often poor for those affected. To enhance care quality, sets of quality indicators (QIs) grounded in c... Read More about AB1607-HPR DEVELOPMENT OF PATIENT-REPORTED QUALITY INDICATORS FOR HAND OSTEOARTHRITIS CARE USING THE RAND/UCLA METHOD – A EUROPEAN CONSENSUS STUDY.

POS0597 PREDICTORS OF PERCEIVED RISK IN FIRST DEGREE RELATIVES OF RHEUMATOID ARTHRITIS PATIENTS (2025)
Presentation / Conference Contribution
Bunnewell, S., Wells, I., Zemedikun, D., Simons, G., Mallen, C., Raza, K., & Falahee, M. POS0597 PREDICTORS OF PERCEIVED RISK IN FIRST DEGREE RELATIVES OF RHEUMATOID ARTHRITIS PATIENTS. Presented at EULAR 2022, Copenhagen, Denmark

Background
Risk of rheumatoid arthritis (RA) is 3-5 times higher in first-degree relatives (FDRs). Efforts are increasing to develop preventive interventions for this at risk group. Risk perception is a key predic... Read More about POS0597 PREDICTORS OF PERCEIVED RISK IN FIRST DEGREE RELATIVES OF RHEUMATOID ARTHRITIS PATIENTS.

POS0608 SWITCHING OF TREATMENT FROM REFERENCE ETANERCEPT TO SANDOZ ETANERCEPT BIOSIMILAR IN PATIENTS WITH RHEUMATIC DISEASES: AN INTERIM ANALYSIS OF REAL-WORLD DATA FROM THE COMPACT STUDY (2025)
Presentation / Conference Contribution
Schmalzing, M., Askari, A., Sheeran, T., Walsh, D., De Toro Santos, J., Vazquez Perez-Coleman, J., Both, C., Furlan, F., Hachaichi, S., & Kellner, H. POS0608 SWITCHING OF TREATMENT FROM REFERENCE ETANERCEPT TO SANDOZ ETANERCEPT BIOSIMILAR IN PATIENTS WITH RHEUMATIC DISEASES: AN INTERIM ANALYSIS OF REAL-WORLD DATA FROM THE COMPACT STUDY. Presented at EULAR 2021, online

Background:
Sandoz etanercept (SDZ ETN) is a biosimilar of etanercept (ETN). COMPACT is an ongoing, non-interventional study, evaluating the effectiveness, safety, and quality of life with SDZ ETN treatment in pat... Read More about POS0608 SWITCHING OF TREATMENT FROM REFERENCE ETANERCEPT TO SANDOZ ETANERCEPT BIOSIMILAR IN PATIENTS WITH RHEUMATIC DISEASES: AN INTERIM ANALYSIS OF REAL-WORLD DATA FROM THE COMPACT STUDY.

POS0640 REAL-WORLD EFFECTIVENESS AND SAFETY OF GP2015 IN PATIENTS WITH RHEUMATIC DISEASES: FINAL RESULTS OF THE COMPACT STUDY (2025)
Presentation / Conference Contribution
Schmalzing, M., Kellner, H., Askari, A., De Toro Santos, J., Vazquez Perez-Coleman, J., Foti, R., Jeka, S., Haraoui, B., Allanore, Y., Rahman, M., Furlan, F., Hachaichi, S., & Sheeran, T. POS0640 REAL-WORLD EFFECTIVENESS AND SAFETY OF GP2015 IN PATIENTS WITH RHEUMATIC DISEASES: FINAL RESULTS OF THE COMPACT STUDY. Presented at EULAR 2022, Copenhagen, Denmark

Background
COMPACT is a non-interventional study evaluating the effectiveness and safety in patients (pts) with rheumatoid arthritis (RA), axial-spondyloarthritis (axSpA) or psoriatic arthritis (PsA) treated with... Read More about POS0640 REAL-WORLD EFFECTIVENESS AND SAFETY OF GP2015 IN PATIENTS WITH RHEUMATIC DISEASES: FINAL RESULTS OF THE COMPACT STUDY.

OP0230 COMORBIDITIES IN PEOPLE WITH OSTEOARTHRITIS IN FOUR EUROPEAN PRIMARY CARE SETTINGS - COMPREHENSIVE EVIDENCE FROM THE ComOA STUDY (2025)
Presentation / Conference Contribution
Swain, S., Coupland, C., Kamps, A., Runhaar, J., Dell’isola, A., Mallen, C., Kuo, C., Doherty, M., Prieto-Alhambra, D., Englund, M., Bierma-Zeinstra, S., & Zhang, W. OP0230 COMORBIDITIES IN PEOPLE WITH OSTEOARTHRITIS IN FOUR EUROPEAN PRIMARY CARE SETTINGS - COMPREHENSIVE EVIDENCE FROM THE ComOA STUDY. Presented at EULAR 2024, Vienna, Austria

Background:
Associations of osteoarthritis (OA) with different comorbidities have gained attention recently. However, there is no literature on the congruency across different large primary care settings.... Read More about OP0230 COMORBIDITIES IN PEOPLE WITH OSTEOARTHRITIS IN FOUR EUROPEAN PRIMARY CARE SETTINGS - COMPREHENSIVE EVIDENCE FROM THE ComOA STUDY.

2783 Addressing depression and loneliness in older adults: findings from the BASIL+ randomised control trial (2025)
Presentation / Conference Contribution
Littlewood, E., Atha, L., Bailey, D., Ryde, E., Shearsmith, L., Baker, H., Heeley, J., McMillan, D., Chew-Graham, C., Baird, K., Fairhurst, C., Hollingsworth, K., Brady, S., Burke, L., Agnew, E., Coventry, P., Traviss-Turner, G., Newbronner, E., Bosanquet, K., Woodhouse, R., …Gilbody, S. (2024, November). 2783 Addressing depression and loneliness in older adults: findings from the BASIL+ randomised control trial. Presented at British Geriatrics Society Autumn Meeting 2024 Abstracts, London

Background Older adults were more likely to be socially isolated during the COVID-19 pandemic, with increased risk of depression and loneliness. The Behavioural Activation in Social Isolation (BASIL+) trial investigated whether a Behavioural Activati... Read More about 2783 Addressing depression and loneliness in older adults: findings from the BASIL+ randomised control trial.

A consensus process to develop a model of care for patients with alcohol use disorder in the general medical setting (2024)
Presentation / Conference Contribution
Sinclair, J., Uhm, S., King, M., Foote, G., Kalk, N., Canvin, K., Case, P., & Philipps, T. (2024, November). A consensus process to develop a model of care for patients with alcohol use disorder in the general medical setting. Presented at SSA Annual Conference, Newcastle upon Tyne, UK

Background and aim

The rise in alcohol-related harm is reflected in increased hospital admissions in non-treatment-seeking people. There is a limited evidence base for what might constitute effective, high-quality care in general medical settings.... Read More about A consensus process to develop a model of care for patients with alcohol use disorder in the general medical setting.

IMPACT OF RELIGION ON FRAMING AND CARING FOR DEMENTIA AMONG MUSLIM ARABS IN QATAR: A QUALITATIVE STUDY (2024)
Presentation / Conference Contribution
Daher-Nashif, S., Hammad, S., & Kane, T. IMPACT OF RELIGION ON FRAMING AND CARING FOR DEMENTIA AMONG MUSLIM ARABS IN QATAR: A QUALITATIVE STUDY. Presented at GSA 2024 Annual Scientific Meeting, “The Fortitude Factor”

Studies have examined how religion plays a major role in framing mental disorders and in shaping caregiving practices. This presentation sheds light on dementia care among Muslim Arabs in Qatar. The presentation will examine how old age and dementia... Read More about IMPACT OF RELIGION ON FRAMING AND CARING FOR DEMENTIA AMONG MUSLIM ARABS IN QATAR: A QUALITATIVE STUDY.

Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide (2024)
Presentation / Conference Contribution
Beksac, M., Gonzalez Garcia, E., Delimpasi, S., Robak, P., Karunanithi, K., De Arriba, F., Radocha, J., Kim, K., Voloshin, S., Zherebtsova, V., Osipov, I., Mateos, M.-V., Zafar, S. F., Pour, L., Spicka, I., Suzuki, K., Du, X., Wilkes, J., Maroj, B., Morris, K., …Dimopoulos, M. A. (2024, December). Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide. Poster presented at 66th American Society of Hematology Annual Meeting, San Diego, California

Background

Use of triplet/quadruplet therapies for 1L multiple myeloma (MM) raises the need for novel combinations at first relapse. In the phase 3 DREAMM-8 (NCT04484623)... Read More about Belantamab Mafodotin Plus Pomalidomide and Dexamethasone Vs Pomalidomide Plus Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: A Subset Analysis in Patients Who Have Received 1 Prior Line of Therapy Including Lenalidomide.

Interpretative Attention Networks for Structural Component Recognition (2024)
Presentation / Conference Contribution
Uniyal, A., Mandal, B., Puhan, N. B., & Bera, P. Interpretative Attention Networks for Structural Component Recognition. Presented at 27th International Conference on Pattern Recognition, Kolkata, India

Bridges are essential for enabling movement during environmental disasters and serve as crucial links for rescue and aid delivery. Effective bridge inspection and maintenance are more critical than ever due to increasing severity and frequency of env... Read More about Interpretative Attention Networks for Structural Component Recognition.

Mannitol For Cerebral Oedema After Intracerebral Haemorrhage (Mace-Ich): A Feasibility Trial (2024)
Presentation / Conference Contribution
Krishnan, K., Craig, J., Dawson, J., Dineen, R., England, T., Havard, D., Hewson, D., Macleod, M., Roffe, C., Sprigg, N., Woodhouse, L., & Bath, P. (2024, December). Mannitol For Cerebral Oedema After Intracerebral Haemorrhage (Mace-Ich): A Feasibility Trial. Poster presented at 19th UK Stroke Forum Conference, Liverpool, UK